Congratulations to the 2014 New Investigator Awardees

The ISCTM Executive Committee congratulates the recipients of the 2014 New Investigator Awards.  Already these awardees are becoming involved with the Society, two of them  supporting manuscript production.  We are pleased with the high quality of submissions each year, and with the engagement of the awardees in the society.  Special thanks to Barry Lebowitz, who was the original champion of the awards  program, as he passes the leadership baton to the new chair Warachal Faison.  New Investigator awards are offered for the Annual meeting each year. The Call for Nominations is issued in the Autumn. If you are interested in receiving the call for nominations announcement please email the Secretariat

Rosie Curiel, Psy.D
University of Miami Miller School of Medicine, Dept of Psychiatry and Behavioral Sciences
Mentor - Jim Mundt, PhD

Maria Perez Rodriguez, MD, PhD
Icahn School of Medicine, Mt. Sinai
Mentor - Jair Soares, MD

Valentino Pironti, BSc, MSc, PhD, CPsychol
Dept of Psychiatry, University of Cambridge
Mentor - Keith Wesnes, PhD

Steven Szabo, MD, PhD
Duke University Medical Center, Psychiatry and Behavioral Sciences
Mentor- Larry Alphs, MD, PhD

Former Award Winners




2014 Autumn Conference

Targeting Cognitive Impairment Across CNS Disorders
6-8 October 2014, Boston, MA

The goal of this program is to provide an update on scientific and regulatory issues regarding cognitive impairment as an important unmet need in several CNS disorders.  The first session will focus on Cognitive Impairment in Schizophrenia (CIAS), an area for which there has been substantial methodological progress.  So this session will focus on “lessons learned.”  The second session in this program will focus on Cognitive Impairment in MDD (CI in MDD), an area where there is much recognition of unmet need, but not a well developed methodology or regulatory pathway.  The final session will target cognitive impairment in bipolar illness and epilepsy, two areas that are in the very early stages of methodological development and regulatory consideration.

Registration will open mid-June.

Posted for Public Access

In order to more widely serve the CNS drug development community, the ISCTM Executive Committee has changed its policy regarding access to ISCTM meeting materials.  In the past these materials were available only to the ISCTM membership, however beginning with the 9th Annual Meeting and moving forward, if speakers authorize, all presentations and videos will be available for Public Access.  (ISCTM 10th Annual Meeting Presentations)